Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677986 · ClinicalTrials.gov registry record · NA
Buprenorphine Treatment Engagement and Overdose Prevention
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03677986: Completed NA study, sponsored by Johns Hopkins University.
NCT03677986 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677986, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Office-based buprenorphine could be expanded to treat many of the opioid users who are not in treatment and who are at great risk for opioid overdose, but effective approaches are needed to help individuals with opioid use disorder initiate and remain in office-based buprenorphine treatment. Investigators propose to develop and pilot test a novel intervention that will combine video-based directly observed therapy and incentives to promote buprenorphine treatment engagement and adherence in out-of-treatment opioid users.
Interventions
- BEHAVIORAL Video DOT+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03677986
The ClinicalTrials.gov registry entry for NCT03677986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Video DOT+ is the first listed.
NCT03677986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03677986 about?
NCT03677986 is a clinical study titled "Buprenorphine Treatment Engagement and Overdose Prevention". Office-based buprenorphine could be expanded to treat many of the opioid users who are not in treatment and who are at great risk for opioid overdose, but effective approaches are needed to help individuals with opioid use disorder initiate and remain in office-based buprenorphine treatment. Investi...
What is the current status of trial NCT03677986?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-05-01. Estimated completion is 2020-10-20.
What interventions are being tested in trial NCT03677986?
The interventions under investigation include: Video DOT+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT03677986?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.